Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)

Clinical trial NCT00783926 · COMPLETED

Trial details

NCT number: NCT00783926
Sponsor: Alachua Government Services, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Pandemic Influenza

Start date: 2008-07-01
Primary completion: 2009-02-01
Enrollment: 422

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.